Listed by the USPTO as DIBRINO, MARIANNE
Tech Center 1600 • Art Units: 1641 1644
This examiner grants 43% of resolved cases
DIBRINO, MARIANNE has resolved 635 cases in Tech Center 1600 and Art Unit 1641. The allowance rate is 42.8%, and the median time to allowance is 1732 days. The interview lift is 42.2%, indicating a strong recorded association between interviews and allowance despite the lower allowance result.
The company portfolio includes Memorial Sloan Kettering Cancer Center, Uti Limited Partnership, and Beijing Mebio Biotechnology Co. Ltd. The listed firms are Adams & Reese LH, BAKER BOTTS L.L.P., and BakerHostetler. The data supports a prosecution approach that gives interviews close attention, while also accounting for the recorded allowance and extended time to allowance.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18157320 | ANTI-C5 ANTIBODIES AND METHODS OF USE | Non-Final OA | Chugai Seiyaku Kabushiki Kaisha |
| 18301048 | TARGETING OF SRC-3 IN IMMUNE CELLS AS AN IMMUNOMODULATORY THERAPEUTIC FOR THE TREATMENT OF CANCER | Final Rejection | Baylor College of Medicine |
| 17918676 | SARS COV-2 SPIKE PROTEIN CONSTRUCT | Non-Final OA | GlaxoSmithKline Biologicals SA |
| 17709510 | INTERFERON ALPHA 2B VARIANTS | Non-Final OA | Teva Pharmaceuticals Australia PTY LTD. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy42.8% of resolved applications examined by Marianne Dibrino were allowed (635 resolved cases), compared with 45.2% across Art Unit 1641 over the last five years.
This examiner's interview lift is +42.2 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.
Applications allowed by Marianne Dibrino took 1,732 days on average from filing to allowance.
Marianne Dibrino examines applications in Art Unit 1641 in Tech Center 1600 (Biotechnology & Pharmaceuticals).
